BKV vs TECH · P/E 7.2, rev $893.8M vs P/E 65, rev $1.22B
BKV Corporation (BKV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
BKV Corporation (BKV) is a oil & gas e&p company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BKV revenue for 2025-12-31 was $893.8M. Net income was $173.1M. Revenue was down 13.9% from 2024-12-31 to 2025-12-31. BKV currently screens at market cap $2.64B and trailing P/E 7.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BKV currently screens at market cap $2.64B and trailing P/E 7.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BKV and TECH stock pages for the full models.
Not investment advice.